Get the Stockscreener App
3.21
3.22%
+0.10
Pre-market:
3.21
Ovid Therapeutics Inc Stock (OVID) Forecast
The Ovid Therapeutics Inc (OVID) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $4.439, representing a +38.29% increase from the current price of $3.21. The highest analyst price target is $6.3113, and the lowest is $2.5668.
Based on our technical indicators, the current sentiment is neutral and OVID could range between $10.51 and $2.898 in 2025. This suggests that investors should exercise caution when entering new positions on OVID, as the market is likely to remain volatile in the near term.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OVID Price Target
Average 4.439
(+38.29% Upside)
Ovid Therapeutics Inc Stock (OVID) Technical Analysis Forecast
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.12 | Neutral |
| STOCH(9,6) | 51.02 | Neutral |
| STOCHRSI(14) | 64.92 | Neutral |
| MACD(12,26) | 0.0074 | Buy |
| ADX(14) | 15.74 | Neutral |
| William %R | -40.00 | Neutral |
| CCI(14) | 28.03 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.206
Buy
|
3.1707
Buy
|
| MA20 |
3.137
Buy
|
3.151
Buy
|
| MA50 |
3.2711
Sell
|
3.2129
Sell
|
| MA100 |
3.3141
Sell
|
3.2904
Sell
|
| MA200 |
3.4339
Sell
|
3.2452
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
Long-term OVID price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Our analysts are offering long term price forecasts for Ovid Therapeutics Inc In 2050, the median target price for OVID is $8.2188, with a high estimate of $9.8297 and a low estimate of $7.957. The median estimate represents a +156.04% increase from the last price of $3.21. Below is our long term OVID Price forecast table with detailed price target for each year.
| Year | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| 2024 | $3.6722 | $2.5668 | $5.0299 | +14.40% |
| 2025 | $6.9029 | $2.898 | $10.51 | +115.05% |
| 2026 | $4.7237 | $3.412 | $8.1366 | +47.16% |
| 2027 | $3.3045 | $2.9223 | $5.0033 | 2.94% |
| 2028 | $5.0203 | $2.7154 | $5.1553 | +56.40% |
| 2029 | $3.8117 | $3.7117 | $5.6009 | +18.75% |
| 2030 | $4.4233 | $3.6035 | $7.3916 | +37.80% |
| 2035 | $5.0211 | $4.6403 | $6.7324 | +56.42% |
| 2040 | $7.4663 | $5.9129 | $8.258 | +132.60% |
| 2045 | $9.1222 | $6.6466 | $9.4122 | +184.18% |
| 2050 | $8.2188 | $7.957 | $9.8297 | +156.04% |
Ovid Therapeutics Inc Stock (OVID) Year by Year Forecast
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2024
For Ovid Therapeutics Inc Stock (OVID) price forecast for 2024, the average price target for Ovid Therapeutics Inc Stock is $3.7983 with a high forecast of $5.0299 and a low forecast of $2.5668. The average OVID price prediction of 2024 represents a +18.33% increase from the last price of $3.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $2.8529 | $2.6859 | $3.1586 | -11.13% |
| June, 2024 | $2.6254 | $2.5854 | $3.2213 | -18.21% |
| July, 2024 | $3.7621 | $2.5668 | $3.8222 | +17.20% |
| August, 2024 | $3.1276 | $3.0826 | $3.9836 | -2.57% |
| September, 2024 | $2.8395 | $2.8104 | $3.2831 | -11.54% |
| October, 2024 | $4.1935 | $2.8058 | $5.0299 | +30.64% |
| November, 2024 | $3.4103 | $3.1547 | $4.4144 | +6.24% |
| December, 2024 | $3.6722 | $3.1367 | $3.9408 | +14.40% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2025
Ovid Therapeutics Inc Stock (OVID) is expected to reach an average price of $6.7032 in 2025, with a high prediction of $10.51 and a low estimate of $2.898. This indicates an +108.82% rise from the last recorded price of $3.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.1226 | $3.6135 | $5.5126 | +59.58% |
| February, 2025 | $5.043 | $4.943 | $6.3113 | +57.10% |
| March, 2025 | $5.0349 | $4.3685 | $5.3144 | +56.85% |
| April, 2025 | $4.2953 | $4.0139 | $5.5612 | +33.81% |
| May, 2025 | $4.0407 | $2.898 | $4.241 | +25.88% |
| June, 2025 | $4.7475 | $3.7221 | $5.1975 | +47.90% |
| July, 2025 | $6.963 | $4.3589 | $7.223 | +116.92% |
| August, 2025 | $8.5284 | $5.9371 | $10.51 | +165.68% |
| September, 2025 | $8.3952 | $7.7198 | $9.3798 | +161.53% |
| October, 2025 | $8.6307 | $7.168 | $8.8907 | +168.87% |
| November, 2025 | $6.6161 | $6.1661 | $9.5021 | +106.11% |
| December, 2025 | $6.9029 | $6.4275 | $8.0389 | +115.05% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2026
The 2026 price forecast for Ovid Therapeutics Inc Stock (OVID) stands at an average of $5.7743. Projections range from a high of $8.1366 to a low of $3.412, signifying an +79.88% increase from the previous price of $3.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.2484 | $6.1684 | $7.4043 | +94.65% |
| February, 2026 | $7.4438 | $5.9698 | $7.5818 | +131.90% |
| March, 2026 | $3.7706 | $3.6179 | $8.1366 | +17.47% |
| April, 2026 | $3.8761 | $3.412 | $3.9061 | +20.75% |
| May, 2026 | $4.6415 | $3.7574 | $5.1415 | +44.60% |
| June, 2026 | $5.1483 | $3.7529 | $5.9243 | +60.38% |
| July, 2026 | $4.9638 | $4.7438 | $5.3211 | +54.64% |
| August, 2026 | $5.1306 | $4.4012 | $5.2506 | +59.83% |
| September, 2026 | $5.566 | $5.002 | $5.9933 | +73.40% |
| October, 2026 | $5.1415 | $4.9315 | $5.6274 | +60.17% |
| November, 2026 | $5.2483 | $4.7842 | $5.4083 | +63.50% |
| December, 2026 | $4.7237 | $4.446 | $5.2597 | +47.16% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2027
For 2027, the average price target for Ovid Therapeutics Inc Stock (OVID) is $3.9628, with a high forecast of $5.0033 and a low forecast of $2.9223. This indicates an +23.45% increase from the last price of $3.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.5692 | $4.4992 | $4.8751 | +42.34% |
| February, 2027 | $4.8246 | $4.4304 | $5.0033 | +50.30% |
| March, 2027 | $4.4914 | $4.4514 | $4.9674 | +39.92% |
| April, 2027 | $4.4869 | $4.2569 | $4.835 | +39.78% |
| May, 2027 | $4.3437 | $4.2437 | $4.761 | +35.32% |
| June, 2027 | $4.3991 | $3.84 | $4.4691 | +37.04% |
| July, 2027 | $4.5846 | $4.1419 | $4.7946 | +42.82% |
| August, 2027 | $4.4714 | $4.2187 | $4.8059 | +39.30% |
| September, 2027 | $4.0168 | $3.9957 | $4.6127 | +25.13% |
| October, 2027 | $3.0123 | $2.9223 | $4.3682 | -6.16% |
| November, 2027 | $3.1891 | $2.925 | $3.3564 | -0.65% |
| December, 2027 | $3.3045 | $3.1204 | $3.5532 | +2.94% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2028
Ovid Therapeutics Inc Stock (OVID) is estimated to achieve an average price of $3.9354 in 2028, with a high projection of $5.1553 and a low estimate of $2.7154. This suggests an +22.60% rise from the preceding price of $3.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4413 | $3.2173 | $3.5736 | +7.21% |
| February, 2028 | $3.4768 | $3.1804 | $3.5527 | +8.31% |
| March, 2028 | $3.0422 | $3.0422 | $3.4881 | -5.23% |
| April, 2028 | $2.9377 | $2.8236 | $3.1335 | -8.48% |
| May, 2028 | $3.0845 | $2.7154 | $3.1545 | -3.91% |
| June, 2028 | $3.0199 | $2.9386 | $3.1986 | -5.92% |
| July, 2028 | $3.8567 | $3.0014 | $3.8567 | +20.15% |
| August, 2028 | $3.8422 | $3.6408 | $3.9122 | +19.69% |
| September, 2028 | $3.3376 | $3.2376 | $3.8649 | +3.98% |
| October, 2028 | $4.4444 | $3.239 | $4.5444 | +38.46% |
| November, 2028 | $4.9699 | $4.2158 | $5.0485 | +54.82% |
| December, 2028 | $5.0203 | $4.6812 | $5.1553 | +56.40% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2029
The 2029 price forecast for Ovid Therapeutics Inc Stock (OVID) is $4.6563 on average, with a high prediction of $5.6009 and a low estimate of $3.7117. This represents an +45.06% increase from the previous price of $3.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.7621 | $4.5226 | $5.338 | +48.35% |
| February, 2029 | $4.9576 | $4.6835 | $4.9962 | +54.44% |
| March, 2029 | $5.328 | $4.4653 | $5.5119 | +65.98% |
| April, 2029 | $5.0198 | $4.7144 | $5.4244 | +56.38% |
| May, 2029 | $4.8553 | $4.6353 | $5.3512 | +51.25% |
| June, 2029 | $4.6407 | $4.4907 | $5.0744 | +44.57% |
| July, 2029 | $4.7475 | $3.9648 | $4.9421 | +47.90% |
| August, 2029 | $4.4227 | $4.4227 | $5.1001 | +37.78% |
| September, 2029 | $5.2836 | $4.3454 | $5.6009 | +64.60% |
| October, 2029 | $3.9172 | $3.7472 | $5.3863 | +22.03% |
| November, 2029 | $3.9481 | $3.88 | $4.1427 | +22.99% |
| December, 2029 | $3.8117 | $3.7117 | $4.1863 | +18.75% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2030
Ovid Therapeutics Inc Stock (OVID) is expected to reach an average price of $5.4976 in 2030, with a high forecast of $7.3916 and a low forecast of $3.6035. This signifies an +71.26% surge from the last price of $3.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.7769 | $3.7026 | $4.2526 | +17.66% |
| February, 2030 | $3.6735 | $3.6035 | $3.8553 | +14.44% |
| March, 2030 | $4.8043 | $3.6062 | $4.8644 | +49.67% |
| April, 2030 | $4.1179 | $4.098 | $5.0271 | +28.28% |
| May, 2030 | $3.8939 | $3.8607 | $4.3362 | +21.31% |
| June, 2030 | $5.2534 | $3.8616 | $6.0898 | +63.66% |
| July, 2030 | $4.2734 | $4.2034 | $5.477 | +33.13% |
| August, 2030 | $4.7443 | $4.2361 | $5.0116 | +47.80% |
| September, 2030 | $6.6479 | $4.687 | $6.8079 | +107.10% |
| October, 2030 | $6.1038 | $5.8488 | $7.3916 | +90.15% |
| November, 2030 | $6.1247 | $5.457 | $6.2297 | +90.80% |
| December, 2030 | $4.4233 | $4.1433 | $6.6524 | +37.80% |
0.08%
0.44%
Cap:
|
Volume (24h):